Day: August 6, 2021

SANTA CLARA, Calif., Aug. 06, 2021 (GLOBE NEWSWIRE) — Applied Materials, Inc. will hold a webcast to discuss its third quarter of fiscal 2021 financial results on Thursday, Aug. 19, 2021 at 4:30 p.m. ET / 1:30 p.m. PT. The live webcast will be accessible via the Applied Materials website at: https://ir.appliedmaterials.com. A replay will be available on the same day beginning at 8:00 p.m. ET / 5:00 p.m. PT. About Applied MaterialsApplied Materials, Inc. (Nasdaq: AMAT) is the leader in materials engineering solutions used to produce virtually every new chip and advanced display in the world. Our expertise in modifying materials at atomic levels and on an industrial scale enables customers to transform possibilities into reality. At Applied Materials, our innovations make possible a better future. Learn more at www.appliedmaterials.com. Contact:Ricky...

LEXINGTON, Mass., Aug. 06, 2021 (GLOBE NEWSWIRE) — Kaleido Biosciences, Inc. (Nasdaq: KLDO), a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health, today announced that CFO William Duke will participate in a fireside chat at the Canaccord Genuity Growth Conference at 2:30PM ET on Thursday, August 12. The webcast of the presentation will be made available in the Investors & Media section of Kaleido’s website at https://investors.kaleido.com/events-presentations. An archived replay will be available for 90 days following the event. About Kaleido BiosciencesKaleido Biosciences is a clinical-stage healthcare company with a differentiated, chemistry-driven approach to targeting the microbiome to treat disease and improve human health....

TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) — IBI Group (TSX:IBG) has been selected by the City of Toronto to operate the Road Emergency Services Communications Unit (RESCU) Traffic Operations Centre (TOC) for a period of up to five years. In addition to operations, the firm will provide professional services and traffic management solutions, enhancing the management of the street and highway traffic networks throughout one of North America’s largest cities. IBI will leverage its extensive experience in traffic management, alongside its smart city product offerings — including its CurbIQ™ and Travel-IQ™ solutions — to address Toronto’s multimodal transportation landscape; supporting improved road safety and the efficient movement of goods and people across the city. “This notable award brings together expertise from across our Intelligence...

Aiki delivers CBT and IPT therapies using chatbot which also includes the Yuru voice analysis solution that takes in other health data from apple and google HealthKit to make a more accurate analysis of one’s mental health. AVENTURA, Fla., Aug. 06, 2021 (GLOBE NEWSWIRE) — Life Clips, Inc. (OTC Pink: LCLP) (the “Company”) announced today that its subsidiary Cognitive Apps Software Solutions unveiled Aiki, an AI-based interactive assistant that makes it easy to measure, understand, and improve the mental health of employees. Aiki was developed to capitalize on the trend towards artificial intelligence platforms utilized by employers to raise awareness of employees’ mental health. Aiki will target corporate users who want to use Cognitive Apps voice biomarkers to target improved employee mental health. Many employers have found their...

Canaccord Genuity 41st Annual Growth Conference being held virtually on August 10-12, 2021 HC Wainwright Ophthalmology Virtual Conference on August 17, 2021 FARMINGTON HILLS, Mich., Aug. 06, 2021 (GLOBE NEWSWIRE) — Ocuphire Pharma, Inc. (Nasdaq: OCUP), a clinical-stage ophthalmic biopharmaceutical company focused on developing and commercializing therapies for the treatment of several eye disorders, today announced that Mina Sooch, President and Chief Executive Officer will be participating in a fireside chat on Thursday, August 12, 2021, and one-on-one investor meetings throughout the virtual Canaccord Genuity 41st Annual Growth Conference. On Tuesday August 17, 2021, Ms. Sooch will also be presenting a corporate overview highlighting recent positive Phase 2 data in the Nyxol program, presbyopia, participating in an innovative...

MONTREAL, Aug. 06, 2021 (GLOBE NEWSWIRE) — Knight Therapeutics Inc. (TSX: GUD) (“Knight”), a leading pan-American (ex-USA) specialty pharmaceutical company, will release its second quarter 2021 financial results on Friday, August 13, 2021 prior to market opening. Following the release, Knight will hold a conference call and audio webcast. Knight cordially invites all interested parties to participate in this call. Date: Friday, August 13, 2021Time: 8:30 a.m. ETTelephone: Toll Free: 800-437-2398 or International 1-647-792-1240Webcast: www.gud-knight.com or WebcastThis is a listen-only audio webcast. Media Player is required to listen to the broadcast.Replay: An archived replay will be available for 30 days at www.gud-knight.com.________________________________________ About Knight Therapeutics Inc. Knight Therapeutics Inc., headquartered...

JENA, Germany, Aug. 06, 2021 (GLOBE NEWSWIRE) — InflaRx (Nasdaq: IFRX), a clinical-stage biopharmaceutical company developing anti-inflammatory therapeutics by targeting the complement system, will present at the BTIG Virtual Biotechnology Conference on August 10. A BTIG analyst will host a fireside chat with Prof. Niels C. Riedemann, Chief Executive Officer and Founder of InflaRx, to discuss the Company’s pipeline and upcoming catalysts on Tuesday, August 10 at 9:00am EDT. The Company will also hold virtual 1X1 meetings. About InflaRx N.V.:InflaRx (Nasdaq: IFRX) is a clinical-stage biopharmaceutical company focused on applying its proprietary anti-C5a technology to discover and develop first-in-class, potent and specific inhibitors of C5a. Complement C5a is a powerful inflammatory mediator involved in the progression of a wide...

Reaffirms 2021 guidance with bias to high end of range Announces inaugural dividend of $0.60 per share Completed successful spinoff from DTE Energy Solidly positioned DT Midstream as a premier independent midstream companyDETROIT, Aug. 06, 2021 (GLOBE NEWSWIRE) — DT Midstream, Inc. (NYSE: DTM) today announced second quarter 2021 reported net income of $68 million, or $0.70 per diluted share. For the second quarter of 2021, operating earnings were $89 million and adjusted EBITDA was $191 million. Reconciliations of operating earnings and adjusted EBITDA (non-GAAP measures) to reported net income are included at the end of this news release. “Our successful transition to an independent company and today’s second quarter results reinforce our financial strength and position DT Midstream for continued growth as we work to drive...

Amended agreement with Ginkgo Bioworks to accelerate commercialization of cultured cannabinoids Announced strategic investment in PharmaCann, a leading U.S. cannabis company Spinach™ launched new products in the edible, concentrate, and flower categories in Canada TORONTO, Aug. 06, 2021 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), today announces its 2021 Second Quarter business results. “This quarter, Cronos Group continued to bring high-quality and insight-driven products to market. I am particularly proud of the Spinach™ brand gummy innovation launched this quarter into the Canadian adult-use market, SOURZ by Spinach™, which has quickly jumped to be one of the most desirable products in the edibles category. In the U.S., we officially re-launched PEACE+™ in the direct-to-consumer...